KIT and ovarian cancer: Zhang et al isolated and characterized ovarian cancer-initiating cells (OCICs) from primary ovarian tumors using CD44 and CD117 antibodies, which were fully capable of re-establishing their original tumor hierarchy in vivo, indicating that both CD44 and CD117 positive cells are OCSCs (Zhang, Balch et al. 2008).